Valuation: Linc AB

Market Cap 4.26B 445M 387M 355M 331M 627M 42.33B 636M 1.66B 20.7B 1.67B 1.63B 71.78B P/E 2024
3.84x
P/E 2025 -10.1x
Enterprise Value 3.97B 415M 361M 331M 309M 585M 39.5B 594M 1.55B 19.32B 1.56B 1.52B 66.99B EV / Sales 2024
3.45x
EV / Sales 2025 -9.06x
Free-Float
36.64%
Yield 2024 *
-
Yield 2025 -
1 day+1.80%
1 week+5.00%
Current month+3.38%
1 month+2.94%
3 months+2.51%
6 months+6.68%
Current year+5.45%
1 week 69.8
Extreme 69.8
73.7
1 month 66.6
Extreme 66.6
73.7
Current year 58.9
Extreme 58.9
78.1
1 year 58.9
Extreme 58.9
83.6
3 years 52.2
Extreme 52.2
103.4
5 years 43.8
Extreme 43.8
109.9
10 years 43.8
Extreme 43.8
118.2
Manager TitleAgeSince
Chief Executive Officer 52 2019-12-31
Director of Finance/CFO 44 2019-12-31
Director TitleAgeSince
Chairman 73 1990-12-31
Director/Board Member 52 2019-12-31
Director/Board Member 60 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
04-27Buy

Director

3,000 0.0052%
04-27Buy

Director

20,000 0.0345%
04-24Buy

Director

9,000 0.0155%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+5.00%-3.67%+17.04% 441M
+1.33%+2.70%+15.15%-3.18% 157M
Average +1.56%+3.85%+5.74%+6.93% 299.14M
Weighted average by Cap. +1.68%+4.40%+1.27%+11.73%

Financials

2024 2025
Net sales 1.29B 135M 117M 108M 100M 190M 12.84B 193M 503M 6.28B 506M 495M 21.77B -414M -43.26M -37.6M -34.55M -32.18M -61.02M -4.12B -61.88M -161M -2.01B -162M -159M -6.98B
Net income 1.3B 136M 118M 109M 101M 192M 12.94B 195M 507M 6.33B 510M 499M 21.95B -400M -41.76M -36.29M -33.35M -31.06M -58.9M -3.97B -59.74M -156M -1.94B -157M -153M -6.74B
Net Debt -550M -57.44M -49.91M -45.87M -42.72M -81.01M -5.47B -82.16M -214M -2.67B -215M -211M -9.27B -284M -29.67M -25.79M -23.7M -22.07M -41.85M -2.82B -42.45M -111M -1.38B -111M -109M -4.79B
Logo Linc AB
Linc AB is a Sweden-based investment company. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The Company works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.
Employees
2
Date Price Change Volume
26-07-03 SEK 73.50 +1.80% 18,441
26-07-02 SEK 72.20 +0.98% 34,244
26-07-01 SEK 71.50 +0.56% 24,544
26-06-30 SEK 71.10 +1.86% 39,377
26-06-29 SEK 69.80 -0.29% 14,539
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
73.50SEK
Average target price
71.00SEK
Spread / Average Target
-3.40%
  1. Stock Market
  2. Stocks
  3. LINC Stock